CoChat
Sign Up
Cited by 1,038Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy

Shimomura, Iichiro, Hammer, Robert E., Ikemoto, Shinji, Brown, Michael S., Goldstein, Joseph L.·1999·Nature
DOI 10.1038/43448
Open this paper in CoChat — free account

Abstract

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a paucity of adipose (fat) tissue which is evident at birth and is accompanied by a severe resistance to insulin, leading to hyperinsulinaemia, hyperglycaemia and enlarged fatty liver. We have developed a mouse model that mimics these features of CGL: the syndrome occurs in transgenic mice expressing a truncated version of a nuclear protein known as nSREBP-1c (for sterol-regulatory-element-binding protein-1c) under the control of the adipose-specific aP2 enhancer. Adipose tissue from these mice was markedly deficient in messenger RNAs encoding several fat-specific proteins, including leptin, a fat-derived hormone that regulates food intake and energy metabolism. Here we show that insulin resistance in our lipodystrophic mice can be overcome by a continuous systemic infusion of low doses of recombinant leptin, an effect that is not mimicked by chronic food restriction. Our results support the idea that leptin modulates insulin sensitivity and glucose disposal independently of its effect on food intake, and that leptin deficiency accounts for the insulin resistance found in CGL.

Integrity signals

Registry

Crossref · 10.1038/43448

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Leptin treatment reversed insulin resistance in a fat-specific aP2-SREBP-1c knockout mouse model of congenital generalized lipodystrophy.

    “Shimomura et al. have demonstrated that leptin treatment reversed insulin resistance in a fat-specific aP2-SREBP-1c knockout mouse model of congenital generalized lipodystrophy (4).”

    From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [4]

  • Taken together, the data suggest that the intrahepatic and intramyocellular lipid lowering effects of leptin were mediated mostly by a reduction in energy intake, as opposed to a leptin-induced increase in energy expenditure, although a lipolytic effect of leptin on these tissues cannot be ruled out.

    “Taken together, these data suggest that intrahepatic and intramyocellular lipid lowering effects of leptin were mediated mostly by a reduction in energy intake, as opposed to a leptininduced increase in energy expenditure, although a lipolytic effect of leptin on these tissues cannot be ruled out (4, 28).”

    From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [4]

  • Leptin deficiency contributes to insulin resistance and diabetes in lipodystrophy.

    “Several lines of evidence from both humans and rodent models suggest that leptin deficiency contributes to insulin resistance and diabetes in this setting (139, 168, 169).”

    From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [168]

  • The diabetes phenotype of lipodystrophic mice is ameliorated by leptin administration via a mechanism at least in part independent of food intake and body weight.

    “the diabetes phenotype of these lipodystrophic mice is also ameliorated by leptin administration via a mechanism that is, at least in part, independent of its effect on food intake and body weight (64, 168).”

    From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [168]

  • Recombinant leptin administration could ameliorate dyslipidemia, insulin resistance, and diabetes in rodent models and preliminary short-term human studies.

    “First in rodent models (5) and then in preliminary short-term studies in humans (6), it was shown that recombinant leptin administration could ameliorate dyslipidemia, insulin resistance, and diabetes.”

    From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [5]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L.
Affiliations
  • Howard Hughes Medical Institute (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
  • Brown, Michael S.
  • Goldstein, Joseph L.
ORCID
Venue
Nature
Publisher
Springer Science and Business Media LLC
Published
1999-09
Volume
401
Issue
6748
Pages
73-76
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
DOI
10.1038/43448
OpenAlex
W1492605893
Cited by
1,038
References
15
Citations by year
2026: 5 · 2025: 7 · 2024: 22 · 2023: 24 · 2022: 19 · 2021: 20 · 2020: 20 · 2019: 23 · 2018: 31 · 2017: 29 · 2016: 30 · 2015: 38 · 2014: 36 · 2013: 39 · 2012: 43
FWCI
23.91
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
leptin, congenital generalized lipodystrophy, insulin resistance, diabetes mellitus, transgenic mouse model, adipose tissue, hyperinsulinemia, hyperglycemia, hepatic steatosis, glucose disposal, dietary restriction, energy metabolism
MeSH terms
Animals, Diabetes Mellitus, Experimental, Disease Models, Animal, DNA-Binding Proteins, Female, Food Deprivation, Humans, Insulin Resistance, Lipodystrophy, Liver, Male, Mice, Obese, Mice, Transgenic, Nuclear Proteins, Promoter Regions, Genetic, Proteins, Transcription Factors, Adipocytes, Leptin, CCAAT-Enhancer-Binding Proteins, Mice, Sterol Regulatory Element Binding Protein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review